SCHEMBL765469

SCHEMBL765469

O=c1[nH]nc(O)c2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
PRMT5 O14744 1/20 0.53
LMNA P02545 1/20 0.53
KDM4E B2RXH2 3/20 0.51
POLB P06746 4/20 0.50
PARP1 P09874 3/20 0.50
AR P10275 1/20 0.50
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 2/20 0.49
GAA P10253 2/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 1/20 0.49
THRB P10828 1/20 0.49
HTT P42858 1/20 0.49
RECQL P46063 1/20 0.49
BLM P54132 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.47
CYP1A2 P05177 1/20 0.47
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29934330 0.98 ATM (0.55) ATMNPSR1PRMT5LMNAKDM4E
SCHEMBL21381322 0.98 ATM (0.55) ATMNPSR1PRMT5LMNAKDM4E
SCHEMBL8686734 0.76 PARP1 (0.51) ATMNPSR1PRMT5LMNAKDM4E
SCHEMBL1032659 0.76 PRMT5 (0.60) ATMNPSR1PRMT5LMNAKDM4E
SCHEMBL26732566 0.75 PRMT5 (0.46) ATMNPSR1PRMT5PARP1ALDH1A1
SCHEMBL1904310 0.75 ATM (0.73) ATMNPSR1LMNAKDM4EPOLB
SCHEMBL29363334 0.75 ATM (0.73) ATMNPSR1LMNAKDM4EPOLB
SCHEMBL555280 0.74 ATM (0.57) ATMNPSR1PRMT5LMNAPOLB
SCHEMBL8808348 0.74 ATM (0.57) ATMNPSR1PRMT5LMNAKDM4E
SCHEMBL9766383 0.74 ATM (0.57) ATMNPSR1PRMT5LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4307898-A1 COMPOSITIONS AND METHODS FOR DECONTAMINATION OF SURFACES Aviraban, LLC (US) 2024-01-24 EP claimed
CN-107082764-B Polyhydroxyl phthalazinone compounds, preparation method and application 上海锐聚恩新药研发有限公司 2018-11-02 CN claimed
CN-107082764-A Polyhydroxyl phthalazinone compounds, its preparation method and application 上海锐聚恩新药研发有限公司 2017-08-22 CN claimed
US-20050033050-A1 Phthalazinones and the use thereof in order to combat undesirable microorganisms BAYER CROPSCIENCE AG (DE) 2005-02-10 US claimed
EP-1430035-A1 PHTHALAZINONES AND THE USE THEREOF IN ORDER TO COMBAT UNDESIRABLE MICROORGANISMS Bayer CropScience AG (DE) 2004-06-23 EP claimed
WO-2003024938-A1 PHTHALAZINONES AND THE USE THEREOF IN ORDER TO COMBAT UNDESIRABLE MICROORGANISMS BAYER CROPSCIENCE AG (DE) 2003-03-27 WO claimed
CN-107082764-B Polyhydroxyl phthalazinone compounds, preparation method and application 上海锐聚恩新药研发有限公司 2018-11-02 CN disclosed
CN-107082764-B Polyhydroxyl phthalazinone compounds, preparation method and application 上海锐聚恩新药研发有限公司 2018-11-02 CN disclosed
CN-107082764-A Polyhydroxyl phthalazinone compounds, its preparation method and application 上海锐聚恩新药研发有限公司 2017-08-22 CN disclosed
CN-107082764-A Polyhydroxyl phthalazinone compounds, its preparation method and application 上海锐聚恩新药研发有限公司 2017-08-22 CN disclosed
US-9278098-B2 Substituted phthalazines for inducing insulin secretion and protecting beta-cells UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2016-03-08 US disclosed
US-9278098-B2 Substituted phthalazines for inducing insulin secretion and protecting beta-cells UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2016-03-08 US disclosed
US-20150164892-A1 LISOFYLLINE ANALOGS AND METHODS FOR USE UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2015-06-18 US disclosed
WO-2007027719-A2 LISOFYLLINE ANALOGUES AND THEIR PHARMEACUETICAL USES UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2007-03-08 WO disclosed
US-20050033050-A1 Phthalazinones and the use thereof in order to combat undesirable microorganisms BAYER CROPSCIENCE AG (DE) 2005-02-10 US disclosed
EP-1430035-A1 PHTHALAZINONES AND THE USE THEREOF IN ORDER TO COMBAT UNDESIRABLE MICROORGANISMS Bayer CropScience AG (DE) 2004-06-23 EP disclosed
WO-2003024938-A1 PHTHALAZINONES AND THE USE THEREOF IN ORDER TO COMBAT UNDESIRABLE MICROORGANISMS BAYER CROPSCIENCE AG (DE) 2003-03-27 WO disclosed
CN-1202800-A Herbicidal composition NOVARTIS AG (CH) 1998-12-23 CN disclosed
CN-1144526-A Thiazolidines and oxazolidines substituted by pyridine ring and their use a hypoglycemic agents NISSAN CHEMICAL IND LTD (JP) 1997-03-05 CN disclosed
US-4112080-A INSECTICIDE, MITICIDE, NEMATOCIDE BAYER AKTIENGESELLSCHAFT (DE) 1978-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164892-A1 LISOFYLLINE ANALOGS AND METHODS FOR USE IAPP, RNASE1, CTSA ATM 1855/4885NPSR1 1246/4885PRMT5 3241/4885
US-20050033050-A1 Phthalazinones and the use thereof in order to combat undesirable microorganisms PGLS, DCXR, C5 ATM 3646/4885NPSR1 209/4885PRMT5 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.